| P2093 | author name string | Lawson DH | |
| P2860 | cites work | Statistical aspects of the analysis of data from retrospective studies of disease | Q27860916 |
| | Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms | Q28318050 |
| | Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens | Q28320364 |
| | Factors determining physician reporting of adverse drug reactions. Comparison of 2000 spontaneous reports with surveillance studies at the Massachusetts General Hospital | Q72330224 |
| | Adverse reactions to drugs | Q72577243 |
| | STUDIES ON THE EPIDEMIOLOGY OF ADVERSE DRUG REACTIONS. I. METHODS OF SURVEILLANCE | Q76773409 |
| | Ill-health Due to Drugs | Q84950372 |
| | Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone | Q28331944 |
| | Comprehensive Drug Surveillance | Q30241219 |
| | Thrombocytopenia. II. Drug-induced thrombocytopenia | Q33468477 |
| | Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program | Q34217813 |
| | Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women | Q34235675 |
| | Adverse drug reactions. A critical review | Q34994546 |
| | Anticonvulsants and parental epilepsy in the development of birth defects | Q39367479 |
| | Vaccination against whooping-cough. Efficacy versus risks | Q39419236 |
| | Frequency of eye complaints and rashes among patients receiving practolol and propranolol | Q39450632 |
| | Mortality among women participating in the Oxford/Family Planning Association contraceptive study | Q39455158 |
| | Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program | Q39754766 |
| | Retrospective studies. A review for the clinician | Q39963562 |
| | Unwanted effects of drugs | Q40060921 |
| | A symptom questionnaire for hypertensive patients | Q43318477 |
| | Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance | Q43735952 |
| | Maternal drug exposure and fetal abnormalities; Material and methods | Q43816176 |
| | The discovery of drug-induced illness | Q43818754 |
| | Adverse reactions to potassium chloride | Q45140090 |
| | Clozapine-induced agranulocytosis: a situation report up to August 1976. | Q45146842 |
| | Intensive Hospital Monitoring of Adverse Reactions to Drugs | Q49166499 |
| | Evaluation of Spontaneous Reports of Adverse Reactions to Drugs | Q49757635 |
| | Methodology and results of a survey of adverse reactons to a drug in private practice | Q51049020 |
| | Deaths from Drugs. An Analysis of Drug-Induced Deaths Reported to the Swedish Adverse Drug Reaction Committee During a Five-Year Period (1966-1970) | Q52722259 |
| | Jaundice after repeated exposure to halothane: an analysis of Reports to the Committee on Safety of Medicines. | Q52725665 |
| | THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE. | Q53037618 |
| | Letter: Skin reactions to practolol. | Q54191208 |
| | Clinical biostatistics. XX. The epidemiologic trohoc, the ablative risk ratio, and "retrospective" research. | Q54315521 |
| | Mortality in relation to smoking: 20 years' observations on male British doctors | Q55032900 |
| | Regular Aspirin Intake and Acute Myocardial Infarction | Q56038253 |
| | Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"? | Q57386622 |
| | Regular aspirin use and myocardial infarction | Q57946354 |
| | Comprehensive drug surveillance | Q57946471 |
| | DRUG SURVEILLANCE UTILISING NURSE MONITORS An Epidemiological Approach | Q57946623 |
| | The ambiguity of adverse drug reactions | Q59488406 |
| | Monitoring adverse reactions to drugs. | Q64953217 |
| | Clinical trials of drugs from the viewpoint of the academic investigator (a satire) | Q66901167 |
| | Case-control studies in the evaluation of drug-induced illness | Q67260512 |
| | Letter: Skin reactions to practolol | Q68530507 |
| | Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study | Q68623602 |
| | Lincomycin as a cause of pseudomembranous colitis | Q70004584 |
| | Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women | Q70032553 |
| | Reserpine use in relation to breast cancer | Q70032556 |
| | Experience in monitoring drug reactions in outpatients. The Kaiser-Permanente Drug Monitoring System | Q70573502 |
| | Adverse nondrug reactions | Q72090724 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13-18 | |
| P577 | publication date | 1979-01-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Detection of drug-induced disease | |
| P478 | volume | 7 | |